Feeds
189793 items (189793 unread) in 47 feeds
World Health Organization
(226 unread)
-
WHO news (100 unread)
-
Media
(146891 unread)
-
Reuters Health eLine
(2178 unread)
-
CNN Health (2233 unread)
-
NYT > Health (4529 unread)
-
NPR Health and Science (2963 unread)
-
ABC News: Health (6880 unread)
-
CBSnews.com: Health News (7951 unread)
-
BBC Health News (3350 unread)
-
CBC Health and Science News (2744 unread)
-
Australia ABC News: Health
(4827 unread)
-
China Xinghua Health News
(30 unread)
-
New York Times: Health
(6915 unread)
-
USATODAY.com Health - Top Stories (4435 unread)
-
The Seattle Times: Health (5878 unread)
-
International Herald Tribune: Health and Science (6871 unread)
-
HeraldToday.com: Health
-
WebMD Health Headlines
(5193 unread)
-
MedicineNet Daily News (9287 unread)
-
Medical News Today
(39471 unread)
-
iVillage Health
(5439 unread)
-
Topix.net - Health (5497 unread)
-
Newsvine - health
(20220 unread)
Bird Flu
(3072 unread)
-
MSNBC.com: Bird Flu (14 unread)
-
-
Medical News Today - Bird Flu/Avian Flu
(110 unread)
-
Diabetes
(8450 unread)
-
-
Medical News Today - Diabetes
(2206 unread)
-
Cholesterol
(3575 unread)
-
Topix.net - Cholesterol
(2031 unread)
-
Medical News Today - Cholesterol
(373 unread)
-
Cancer
(15146 unread)
-
-
-
Medical News Today - Breast Cancer News
(1731 unread)
-
Medical News Today - Cancer/Oncology News
(5816 unread)
-
HIV
(7272 unread)
-
-
Medical News Today - HIV/AIDS News
(1910 unread)
-
Women
(3823 unread)
-
-
Medical News Today - OBGYN News
(2595 unread)
-
Men
(1338 unread)
-
-
Medical News Today - Men's health News
(630 unread)
-
Medical News Today - Breast Cancer News (6 unread)
-
Study: Preemptive Surgery May Help Prevent Cancer For Some Women
Posted: September 2nd, 2010, 7:00am CDT
A study published in the Journal of the American Medical Association suggests that women with a gene mutation linked to breast and ovarian cancer face lower risks of developing such cancer after receiving mastectomies or having their ovaries removed, The Wall Street Journal reports... -
Breast Cancer Prognosis Prediction Tool: Microsoft Excel-Based Algorithm
Posted: September 2nd, 2010, 6:00am CDT
Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training... -
Study Indicates Targeted Strategies Needed To Find, Prevent And Treat Breast Cancer Among Mexican-origin Women
Posted: September 2nd, 2010, 5:00am CDT
Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer... -
Roche Provides Update On FDA Application For T-DM1
Posted: September 2nd, 2010, 5:00am CDT
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study... -
Surgeons Impact Whether A Woman Gets Breast Reconstruction
Posted: September 2nd, 2010, 3:00am CDT
When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center. Where a woman goes for breast cancer treatment can vary widely - ranging from small private practices to large hospital settings... -
The ASCO Post Publishes Multiple Perspectives On Outcome Of ODAC Meeting Regarding Bevacizumab In Advanced Breast Cancer
Posted: September 2nd, 2010, 3:00am CDT
The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists, oncologists in private practice, third-party payers, and a patient advocate....